Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 28;12(1):114.
doi: 10.3390/cells12010114.

Research Progress on the Predicting Factors and Coping Strategies for Postoperative Recurrence of Esophageal Cancer

Yujie Zhang  1 , Yuxin Zhang  2 , Lin Peng  1 , Li Zhang  1
Affiliations
Review

Research Progress on the Predicting Factors and Coping Strategies for Postoperative Recurrence of Esophageal Cancer

Yujie Zhang et al. Cells. .

Abstract

Esophageal cancer is one of the malignant tumors with poor prognosis in China. Currently, the treatment of esophageal cancer is still based on surgery, especially in early and mid-stage patients, to achieve the goal of radical cure. However, esophageal cancer is a kind of tumor with a high risk of recurrence and metastasis, and locoregional recurrence and distant metastasis are the leading causes of death after surgery. Although multimodal comprehensive treatment has advanced in recent years, the prediction, prevention and treatment of postoperative recurrence and metastasis of esophageal cancer are still unsatisfactory. How to reduce recurrence and metastasis in patients after surgery remains an urgent problem to be solved. Given the clinical demand for early detection of postoperative recurrence of esophageal cancer, clinical and basic research aiming to meet this demand has been a hot topic, and progress has been observed in recent years. Therefore, this article reviews the research progress on the factors that influence and predict postoperative recurrence of esophageal cancer, hoping to provide new research directions and treatment strategies for clinical practice.

Keywords: clinical biomarkers; esophageal cancer; metastasis; molecular markers; postoperative recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sirieix P.L., Fitzgerald R.C. Screening for oesophageal cancer. Nat. Rev. Clin. Oncol. 2012;9:278–287. doi: 10.1038/nrclinonc.2012.35. - DOI - PubMed
    1. Liang H., Fan J., Qiao Y. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol. Med. 2017;14:33–41. - PMC - PubMed
    1. Napierk J., Scheererm M. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J. Gastrointest. Oncol. 2014;6:112–120. doi: 10.4251/wjgo.v6.i5.112. - DOI - PMC - PubMed
    1. Chungc M.M., Leey M.P., Wum M.P. Prevention strategies for esophageal cancer: Perspectives of the East vs. West. Baillière’s Best Pract. Res. Clin. Gastroenterol. 2015;29:869–883. doi: 10.1016/j.bpg.2015.09.010. - DOI - PubMed
    1. Hamai Y., Hihara J., Emi M., Furukawa T., Ibuki Y., Yamakita I., Kurokawa T., Okada M. Treatment Outcomes and Prognostic Factors After Recurrence of Esophageal Squamous Cell carcinoma. World J. Surg. 2017;42:2190–2198. doi: 10.1007/s00268-017-4430-8. - DOI - PubMed

Publication types

MeSH terms